ArticleOncotarget2016

Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis.

Bruno Vincenzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.